TC BioPharm (TCBP) Twitter Followers Statistics 2025

926 0.1%

1W 0% 1M 0% 3M 1.1%

Followers on Twitter.

Similar companies

Company		Twitter Followers
	Amgen AMGN	120,089 0%
	Gilead Sciences GILD	72,819 0%
	Catalyst Pharmaceuticals CPRX	841 0%
	Inovio Pharmaceuticals INO	17,130 0%
	Anavex Life Sciences AVXL	2,095 0%

Month over Month

Followers on Twitter.

Mar 2025	932	1.1%
Feb 2025	922	1.1%
Jan 2025	912	0.5%
Dec 2024	917

How many users are following TC BioPharm on Twitter?

TC BioPharm has 926 followers on Twitter.

Analyzing Twitter Followers, how is TC BioPharm performing compared to its industry peers?

TC BioPharm underperforms its industry peers when it comes to Twitter Followers, ranking dead last.

Why should an investor in TC BioPharm track and monitor Twitter Followers?

Tracking TC BioPharm's Twitter followers offers insights into its brand popularity and customer engagement. A growing follower count signals rising interest in TC BioPharm's products, services and a positive brand image. This metric serves as both a measure of engagement and a crucial audience for marketing strategies. By comparing TC BioPharm's Twitter following with competitors, we gain perspective on its market standing. Although a singular aspect, Twitter followership, when combined with financial and operational data, contributes to a comprehensive understanding of TC BioPharm's overall performance.

How does the current number of Twitter followers impact TC BioPharm's brand presence and market influence?

With fewer than 1,000 followers, TC BioPharm's Twitter account is in its growth phase, focusing on building its audience. This suggests a niche but potentially dedicated following, important for targeted engagement.

About Us

AltIndex revolutionizes investing with advanced alternative data analytics, smart insights, and stock alerts, presented in an easy-to-use dashboard powered by comprehensive company data from across the internet.

Legal Disclaimer
The information provided by AltIndex is solely for informational purposes and not a substitute for professional financial advice. Investing in financial markets carries inherent risks, and past performance doesn't guarantee future results. It's crucial to do your research, consult with financial experts, and align your financial objectives and risk tolerance before investing. AltIndex creators and operators are not liable for any financial losses incurred from using this information. Users should exercise caution, seek professional advice, and be prepared for the risks involved in trading and investing in financial assets, only investing what they can afford to lose. The information in this application, derived from publicly available data, is believed to be reliable but may not always be accurate or current. Users should verify information independently and not solely rely on this application for financial decisions. By using AltIndex, you acknowledge that it doesn't offer financial advice and agree to consult a qualified financial advisor before making investment decisions.